Centaurus Financial, Inc. Exact Sciences Corp Transaction History

Centaurus Financial, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$57.56 - $82.54 $92,383 - $132,476	-1,605 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$72.5 - $100.68 $29,000 - $40,272	-400 Reduced 19.95%	1,605 $125,000
Q1 2021 Apr 30, 2021	BUY	$116.57 - $155.01 $1,748 - $2,325	15 Added 0.75%	2,005 $264,000
Q4 2020 Jan 25, 2021	BUY	$99.61 - $142.12 $2,988 - $4,263	30 Added 1.53%	1,990 $264,000
Q3 2020 Nov 12, 2020	BUY	$72.92 - $102.01 $142,923 - $199,939	1,960 New	1,960 $200,000
Q3 2019 Nov 12, 2019	SELL	$90.37 - $122.49 $90,370 - $122,490	-1,000 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$89.51 - $118.04 $89,510 - $118,040	1,000 New	1,000 $118,000
Q3 2018 Nov 05, 2018	SELL	$48.29 - $80.6 $72,435 - $120,899	-1,500 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$37.84 - $69.96 $56,760 - $104,939	1,500 New	1,500 $90,000

676

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

Stay updated on Centaurus Financial, Inc. with notifications on news.